Anzeige
Mehr »
Mittwoch, 25.06.2025 - Börsentäglich über 12.000 News
TAO +1.800?%, SBAR +85?%, CYK +280?% - jetzt startet KORA auf Unternehmensebene durch!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A40M9J | ISIN: US83558L3033 | Ticker-Symbol: O8Z
Lang & Schwarz
25.06.25 | 07:00
2,480 Euro
-100,00 % -2,480
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
SONOMA PHARMACEUTICALS INC Chart 1 Jahr
5-Tage-Chart
SONOMA PHARMACEUTICALS INC 5-Tage-Chart
RealtimeGeldBriefZeit
2,4402,52007:00

Aktuelle News zur SONOMA PHARMACEUTICALS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
SONOMA PHARMACEUTICALS Aktie jetzt für 0€ handeln
17.06.Sonoma Pharmaceuticals GAAP EPS of -$0.48, revenue of $3.75M4
17.06.Sonoma Pharmaceuticals, Inc.: Sonoma Pharmaceuticals Reports Fiscal Year and Fourth Quarter 2025 Financial Results319Revenues increased 9% in Q4 2025 compared to Q4 2024, and 12% in FY 2025 compared to FY 2024Net loss improved 27% in Q4 2025 compared to Q4 2024, and 29% in FY 2025 compared to FY 2024EBITDA loss improved...
► Artikel lesen
17.06.Sonoma Pharmaceuticals, Inc. - S-8, Securities to be offered to employees in employee benefit plans2
17.06.Sonoma Pharmaceuticals, Inc. - 10-K, Annual Report3
28.04.Sonoma Pharmaceuticals, Inc. - 8-K, Current Report7
22.04.Sonoma Pharmaceuticals, Inc.: Sonoma Pharmaceuticals Announces Registration of Acne Products in the United Kingdom and Launch of the Products in Leading U.K. Pharmacy Chain365BOULDER, CO / ACCESS Newswire / April 22, 2025 / Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a global healthcare leader developing and producing patented Microcyn® technology based stabilized hypochlorous...
► Artikel lesen
07.04.Sonoma Pharmaceuticals, Inc. - 8-K, Current Report1
25.03.Sonoma Pharmaceuticals, Inc. - 8-K, Current Report3
11.03.What's Going On With Sonoma Pharmaceuticals Stock Tuesday?9
11.03.Pre-market Movers: 2seventy bio, Sonoma Pharmaceuticals, Tenon Medical, Arvinas, NET Power Inc.653LONDON (dpa-AFX) - The following are some of the stocks making big moves in Tuesday's pre-market trading (as of 09.00 A.M. ET).In the Green 2seventy bio, Inc. (TSVT) is up over 76% at $4.93. Sonoma...
► Artikel lesen
10.03.Sonoma Pharmaceuticals expands into UK market9
10.03.Sonoma Pharmaceuticals, Inc.: Sonoma Pharmaceuticals Secures Extensive U.K. Regulatory Clearances of Key Wound Care and Dermatology Products by the Medicines & Healthcare Products Regulatory Agency404BOULDER, CO / ACCESS Newswire / March 10, 2025 / Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a global healthcare leader developing and producing patented Microcyn® technology based stabilized hypochlorous...
► Artikel lesen
10.03.Sonoma Pharmaceuticals Stock Surges 39% On Upcoming AAD Annual Meeting Exhibit2
25.02.Sonoma Pharmaceuticals, Inc.: Sonoma Pharmaceuticals to Exhibit at 2025 American Academy of Dermatology Annual Meeting in Orlando383BOULDER, CO / ACCESS Newswire / February 25, 2025 / Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a global healthcare leader developing and producing patented Microcyn® technology based stabilized hypochlorous...
► Artikel lesen
05.02.Sonoma Pharmaceuticals GAAP EPS of -$0.63 beats by $0.06, revenue of $3.6M misses by $0.46M5
05.02.Sonoma Pharmaceuticals, Inc.: Sonoma Pharmaceuticals Reports Third Fiscal Quarter 2025 Financial Results362Revenues increased 14% for the quarter compared to prior year and 13% year-to-datePositive cash flow from operations for the quarter with $5.2 million of cash at December 31, 2024Year-to-date net loss...
► Artikel lesen
05.02.Sonoma Pharmaceuticals, Inc. - 10-Q, Quarterly Report1
30.01.Sonoma Pharmaceuticals, Inc. - 8-K, Current Report-
03.01.Sonoma Pharmaceuticals, Inc. - 8-K, Current Report-
05.12.24Sonoma Pharmaceuticals, Inc.: Sonoma Pharmaceuticals Successfully Transitions First Products to New EU MDR Requirements for Class IIb Medical Devices350BOULDER, CO / ACCESSWIRE / December 5, 2024 / Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a global healthcare leader developing and producing patented Microcyn® technology based stabilized hypochlorous...
► Artikel lesen
Weiter >>
38 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1